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Clinical research indicates that negative calcium balance is associated with low bone mass, rapid bone loss, and high fracture rates.
However,somestudiesrevealedthatnotonlycalciumisinvolvedinbonestrengtheningasriskfactoroffractureosteoporosis.Thus,
inthisreport,thediﬀerenceofmetallicandnonmetallicelementsinosteoporosisandnormalboneswasstudiedbyhigh-resolution
inductively coupled plasma mass spectrometry (HR-ICP-MS). The inﬂuence of these elements on bone metabolic processes is also
discussed.Inclusioncriteriaofbonesamplesconsistofpostmenopausalwoman,trabecularbonefracture,normalandosteoporosis
BMD value, and no history of previous disease. The results showed that the concentration of B, Al, S, V, Co, Mo, Te, Ba, La, Ni,
As, and Ca/P ratio is higher in osteoporosis than normal. These atomic minerals have negative role to imbalance between bone
resorption and bone formation activity. Conversely, concentrations of Na, Mg, P, K, Ca, Cr, Pd, Ag, Mn, Fe, Cu, Zn, Rb, Sr, Pb,
and Se are lower in osteoporosis than in normal bones. Among these atoms, known to have important roles in bone structure, we
found involvement of atomic mineral and calcium which are considerable to contribute to osteoporotic phenomena.
1.Introduction
Decreasing of skeletal strength and increasing of fragility and
fracture risk was a marker of osteoporosis. This condition
is caused by abnormalities of bone density and bone
microstructure [1, 2]. A few studies focusing on osteoporosis
epidemiologyinlessdevelopedordevelopingcountriesmake
the prevalence unclear [3]. The prevalence of osteoporosis
in South East Asia was estimated of about 15.3% [4]. White
paper from Indonesian Osteoporosis Association shows that
prevalence of osteoporosis at 2007 was 28.85% for man and
32.3% for woman [5].
Organic and inorganic components are responsible for
toughness and rigidity of bone, respectively. Both of these
substances also show the mechanical strength of the bone.
Trabecular bone is more sensitive to hormones or other
biological factors that are involved in modulating bone
metabolism [6]. Atomic mineral is the smallest component
of trabecular bone. Calcium is the most prominent mineral
in bone which determines the risk of osteoporosis. Clinical
research indicates that negative calcium balance often occurs
in aged men and postmenopausal women due to several
factors. It appears to be associated with low bone mass, rapid
bone loss, and high fracture rates [7]. Several researches
show inconsistent results. Prentice shows that in Gambia
population who have low calcium daily intake were found to
have lower osteoporosis prevalence [8]. Western population
whose calcium daily intake is of high level were higher in
fracture incidence, conversely in Asian population whose
low calcium was lower in fracture incidence [3, 9]. This2 The Scientiﬁc World Journal
phenomenon indicates that not only calcium is involved in
bone quality as a risk factor of fracture osteoporosis.
Each atomic mineral was able to substitute another
atomic mineral due its similarity in the atomic radius. Ren
et al. showed that Zn substitution on hydroxyl apatite crystal
was found to inhibit crystal growth due to its smaller atomic
radius as compared with Ca [10]. This ﬁnding was also
conﬁrmed by Miyaji et al. [11]. Moreover, several publica-
tions indicate the importance of atomic composition in
bone. ˇ Sˇ canˇ car et al. explore the composition of mineral in
iliac crest autopsy sample by atomic absorption spectrometry
(AAS) and conclude that Zn, Rb, Se, Fe, Al, Cu, Pb are in
mg/g level, and Ca is in g/mg level [12]. Brodziak-Dopierala
e ta l .m e a s u r eN i ,M n ,C r ,C a ,P b ,C u ,F e ,Z n ,M g ,K ,N a ,
and Cd in several head femur sections which indicate its
eﬀectonmechanicalstress[13].Zaichick andTzaphlidou say
that Ca/P ratio is the best predictor to explain bone disorder
[14]. Alfv´ en et al. conclude that low exposure of cadmium
increasesosteoporosisrisk[15].However,almostallprevious
papers explored only few atomic minerals and little associa-
tion with osteoporosis.
So far, no detail information is dealing with the bone
quality of Indonesian people. We just believe that its quality
is not solely determined by calcium, but no explanation
as an answer of the hypothesis of why in Indonesian
population the fracture rate of osteoporosis are low does
not in accordance with the fact of low Calcium intake.
Accordingly, the objective of this study is to investigate the
characteristics of atomic mineral in Indonesian osteoporosis
and normal bone by HR-ICP-MS. About 27 elements were
successfully analyzed, which include B, Al, S, V, Co, Mo, Te,
B a ,L a ,N i ,A s ,N a ,M g ,P ,K ,C a ,C r ,P d ,A g ,M n ,F e ,C u ,Z n ,
Rb, Sr, Pb, and Se. The present study provides more detail
information of atomic mineral compositions as well as better
understanding for the association of atomic mineral (beside
calcium) with osteoporosis.
2. Methods
The study was mainly conducted in the Department of
Orthopaedics, Ulin General Hospital of Banjarmasin and the
DepartmentofOrthopaedics,SyaifulAnwarHospitalofMal-
ang from September 2010 to January 2011. Inclusion criteria
consist of postmenopausal woman, trabecular bone fracture,
normal and osteoporosis BMD value, age less than 50 years,
and no history of previous disease. Bone was obtained in
surgery room and then analysed for its atomic mineral com-
positions using HR-ICP-MS (ELEMENT2, Thermo Fisher
Scientiﬁc, USA) at the Division of Nanomaterial Sciences,
EcoTopia Science Institute, Nagoya University, Japan. The
mineral measured consists of 27 elements, such as B, Al, S, V,
C o ,M o ,T e ,B a ,L a ,N i ,A s ,N a ,M g ,P ,K ,C a ,C r ,P d ,A g ,M n ,
Fe,Cu,Zn,Rb,Sr,Pb,andSe.PriortoICP-MSmeasurement,
dry weight of bone samples were digested with a microwave-
assisted acid digestion system (ETHOS E, Milestone General,
Italy). Approximately 100mg of the sample in a PTFE diges-
tion vessel was weighted, into which 4mL of HNO3 and
1mLofH 2O2 were added. The temperature program of a
Table 1: Average of atomic mineral concentrations which is higher
in osteoporosis bone.
Element
Concentration µgg −1
P value
Normal bone Osteoporosis bone
B 2.49 4.40 0.04
Al 32.91 290.90 0.48
S 2760.17 2775.24 0.42
V 0.10 0.19 0.12
Co 0.02 0.03 0.07
Mo 0.00 0.01 0.29
Te 0.00 0.01 0.68
Ba 2.61 1138.61 0.86
La 0.00 0.02 0.15
Ni 36.57 43.74 0.10
As 0.00 0.01 0.03
Ca/P ratio 0.95 1.08 0.60
B: boron; Al: aluminum; S: sulphur; V: vanadium; Co: cobalt; Mo:
molybdenum; Te: tellurium; Ba: barium; La: lanthanum; Ni: nickel; As:
arsen; Ca/P: calcium/phosphorus; µgg −1:m i c r o g r a m / g r a m .
microwave irradiation was ramped to 220◦C within 15min
and kept at this temperature for 10min. After cooling the
vessels, proper amounts of the internal standard solution
contained Rh and Re were added. Then, all solutions in
the vessels were transferred into polypropylene bottles and
diluted with 0.1M HNO3 (ultrapure grade, Kanto chemical,
Japan) up to 50mL. Minimal samples for normal and osteo-
porosis groups based on Epi Info version 6 were 32 samples
for both groups. Statistical analysis was performed using t
student-test, and P value < 0.05 was considered statistically
signiﬁcant.
3. Results
Fifteen osteoporosis BMD and twenty three normal BMD
values were involved in this study. HR-ICP MS analytical
results showed diﬀerent concentration of atomic minerals in
osteoporosis and normal postmenopausal women. The con-
c e n t r a t i o no fB ,A l ,S ,V ,C o ,M o ,T e ,B a ,L a ,N i ,A s ,a n dC a / P
ratio in osteoporosis bones was found higher than that of
normal bone as shown in Table 1. Lower concentrations of
N a ,M g ,P ,K ,C a ,C r ,P d ,A g ,M n ,F e ,C u ,Z n ,R b ,S r ,P b ,a n d
Se were detected lower in osteoporosis than in normal bones
as given in Table 2.
4. Discussions
Geometrics pattern of bone atomic minerals for substitution
or incorporation is based on the properties of atoms in the
periodic tables of Mendeleev. Substitution is the replacement
of an atom with other atoms due to the similarity of atomic
radius and atomic charge. Incorporation is joining an atom
to a molecule and/or a composite that can alter the integrity
of a molecule. Molecular cavity can also play consider-
able role in substitution or incorporation of atoms. All ofThe Scientiﬁc World Journal 3
Table 2: Average of atomic mineral concentrations which is lower
in osteoporosis bone.
Element
Concentration µgg −1
P value
Normal bone Osteoporosis bone
Na 1248.79 972.75 0.58
Mg 921.06 816.17 0.56
P 63827.16 40757.15 0.42
K 2.02 1.50 0.30
Ca 88964.72 58150.53 0.70
Cr 4.87 1.28 0.82
Pd 10.15 2.40 0.01
Ag 0.08 0.01 0.13
Mn 0.31 0.08 0.70
Fe 224.15 187.32 0.58
Cu 9.39 3.75 0.91
Zn 114.50 47.00 0.60
Rb 1.04 0.32 0.03
Sr 44.90 32.41 0.94
Pb 0.29 0.07 0.58
Se 5.59 1.28 0.02
Na: sodium; Mg: magnesium; P: phosphorus; K: potassium; Ca: calcium;
Cr: chromium; Pd: palladium; Ag: argentum; Mn: manganese; Fe: iron; Cu:
cuprum; Zn: zinc; Rb: rubidium; Sr: strontium; Pb: plumbum; Se: selenium;
µgg −1:m i c r o g r a m / g r a m .
these phenomenons signiﬁcantly aﬀect the properties and
structure of bone crystal.
The concentration of B, Al, S, V, Co, Mo, Te, Ba, La,
Ni, As, and Ca/P ratio in osteoporosis is higher than in
normal bone. These atomic minerals have negative role in
imbalance between bone resorption and bone formation
a c t i v i t y .C o n v e r s e l y ,t h ec o n c e n t r a t i o no fN a ,M g ,P ,K ,C a ,
C r ,P d ,A g,M n ,F e ,C u ,Z n ,R b ,S r ,P b ,a n dS ei no s t e o p o r o s i s
is lower than in normal. Beside that, concentration of B and
As is higher signiﬁcantly (P<0.05) in osteoporosis bone
than in normal bone. Concentration of Pd, Rb, and, Se is
higher signiﬁcantly (P<0.05) in normal bone than osteo-
porosis bone.
As it is well known, plant is a rich source of boron,
but meat and ﬁsh are poor sources of boron [16]. Eﬀect of
boron on bone was still controversial. Nielsen et al. showed
that boron deprivation decreased bone volume fraction and
increasedtrabecularseparation.Additionally,borondepriva-
tion decreased trabecular thickness [17]. In another case,
increased level of boron can strengthen a bone, but it gene-
rates fragility. The increase in chemical resistance of calciﬁed
tissue, which changes a resorption activity, could also be
attributed to the eﬀect of boron in bone [18]. As shown
in Table 1, concentration of boron in osteoporosis bone is
signiﬁcantly higher than in normal bone (P<0.05) and
indicates decrease in a bone mineral density. Since boron
is substitution mineral for phosphorus, the concentration
level of phosphorus in osteoporosis bone would be lower
than in normal bone as observed in this study. Simulation
using crystal maker software shows that the substitution of
Table 3: Eﬀect of boron on atomic density in hydroxyapatite of
osteoporosis and normal bone.
Atomic density/kgm−3
Normal bone Osteoporosis bone
Before boron substitution 3213.49 3188.48
After boron substitution 2829.59 2804.58
Table 4: Porosity of osteoporosis bone for boron substitution.
Filled space/% Void space/%
Before boron substitution 20.71 79.29
After boron substitution 20.84 79.16
phosphorus by boron resulted in decreasing atomic density
for both osteoporosis and normal hydroxyapatite bones as
shown in Table 3. Due to the decrease in atomic density, we
expected that this substitution induces amorphous state in
the osteoporosis bone. However, this is not proven since the
ﬁlled space increased along with the decrease in void space
after boron substitution as given in Table 4.
ˇ Sˇ canˇ car et al. reported that concentration of aluminum
in bone from autopsy subject was 3–10mg/kg [12]. Eﬀect
of aluminum on bone was also still controversial. In vitro
study shows that aluminum induced neo-osteogenesis eﬀect
via direct stimulation on osteoblast activity [19]. In another
case, it was reported that aluminum inhibits bone formation
through reduction of osteoblast activity, osteoid mineraliza-
tion, and matrix formation [20, 21]. In this study, level of
aluminum in osteoporosis is higher than in normal bone. We
suppose that aluminum is involved in the imbalance of bone
formation and resorption activity, probably via reduction
of osteoblast activity, osteoide mineralization, and matrix
formation.
Vanadium, nickel, cobalt, and arsenic are toxic metals
for osteoblast in vitro. High concentration of these metals
induces osteoblast apoptosis [19–22]. In this study, vanadi-
um, nickel, cobalt, and arsenic in osteoporosis bone are
higher than in normal bone, which may result in the inhibi-
tion of bone formation and subsequently contribute to the
imbalance condition between bone formation and resorp-
tion activity. As vanadium and arsenic are substitution min-
erals for phosphorus in hydroxyapatite crystal, further inves-
tigation to ascertain the eﬀect of vanadium and arsenic subs-
titution for phosphorus in osteoporosis bone was simulated
using Crystal Maker software. Although vanadium and ar-
senic substitution resulted in increasing atomic density
(Table 5), however the ﬁlled space of hydroxyapatite de-
creased (Table 6), indicating an increase in crystal porosity.
The highest concentrations of Barium in the body are
found in the bone, and it is primarily deposited in areas
of active bone growth [23] .T h eu p t a k eo fB a r i u mi n t ot h e
bone occurred rapidly. For example, one day after rats were
exposed with barium chloride aerosols, approximately 78%
of Barium was found in the skeleton; by 11 days past the
exposure, more than 95% of barium was found in the skele-
ton [24]. In this study, barium in osteoporosis bone was4 The Scientiﬁc World Journal
Table 5: Atomic density in hydroxyapatite of osteoporosis and
normal bone.
Atomic density/kgm−3
Normal bone Osteoporosis bone
Before vanadium
substitution 3213.49 3188.48
After vanadium
substitution 3597.79 3568.76
Before arsen substitution 3213.49 3188.48
After arsen substitution 4050.41 4025.41
Table 6: Porosity of osteoporosis bone for vanadium and Arsen
substitution.
Filled space/% Void space/%
Before vanadium
substitution 20.71 79.29
After vanadium
substitution 18.40 81.60
Before arsen substitution 20.71 79.29
After arsen substitution 17.92 82.08
Table 7: Atomic density in hydroxyapatite of osteoporosis and
normal bone.
Atomic density/kgm−3
Normal bone Osteoporosis bone
Before barium substitution 3213.49 3188.48
After barium substitution 5681.91 6274.01
Table 8: Porosity osteoporosis bone for barium substitution.
Filled space/% Void space/%
Before barium substitution 20.71 79.29
After barium substitution 27.84 72.16
found higher than in normal bone. This data indicates that
barium is involved in imbalance between bone formation
and resorption in osteoporosis. Barium is substitution atom
for calcium in hydroxyapatite that could be found in the
osteoporosis bone. With crystal maker simulation, substitu-
tion of barium to calcium increases atomic density (Table 7)
and decreases porosity of hydroxyapatite osteoporosis bone
as indicated by increases in ﬁlled space (Table 8).
Iron has a role in bone formation as an enzymatic
cofactor for the synthesis of collagen. Calcium could inhibit
the iron formation. Beside that, iron is also toxic for bone
cell, which can induce osteoporosis by disturbing bone min-
eralization [18, 25]. ˇ Sˇ canˇ car et al. reported that concentra-
tionofironinbonefromautopsysubjectwas100–200mg/kg
[12]. In this study, iron level in normal bone is higher than
osteoporosis bone. Iron in normal bone is essential for the
synthesis of collagen.
ˇ Sˇ canˇ car et al. also found that concentration of copper in
bone from autopsy subject was 100–200mg/kg [12]. Copper
makes a crosslink with collagen. Copper was antagonist for
zinc in bone, which means that increasing copper induces
decreasing zinc level [26]. Copper deﬁciency decreases
osteoblast activity and induces osteoporosis [27]. In this
study, we found deﬁciency of copper in osteoporosis bone.
Additionally, there is no inverse correlation between copper
and zinc, indicating no toxic eﬀect of these metals on bone
cell.
Magnesium was not a main component in hydoxyapatite
crystal but was able to join with this crystal. Magnesium is
substitution mineral for calcium in composite hydroxyap-
atite crystal [28]. Magnesium deﬁciency was a risk factor of
osteoporosis [2, 29, 30] .Ap r e v i o u ss t u d yc o n c l u d e dt h a t
magnesium level among osteoporosis subjects was signiﬁ-
cantly lower than nonosteoporosis [31]. Magnesium acts as a
mitogenic factor for bone cell, and its depletion can cause
cellular growth inhibition in vitro. Magnesium deﬁciency
induces decreasing collagen formation, sulfation of glycos-
aminoglycan,andtetracyclinelabeling[32–34].Inthisstudy,
deﬁciency of magnesium is found in osteoporosis bone. This
deﬁciency probably induces inhibition of cellular growth
and decreasing collagen formation in osteoporosis bone.
Moreover, it was found that magnesium is not substitution
mineral for calcium.
Manganese was prominent atomic for mucopolysaccha-
ride metabolism that aﬀects the organic matrix formation.
Manganese was able to substitute calcium due to similar oxi-
dation state. In osteoporosis patient, manganese was found
in low level [18, 24]. Prolonged manganese deﬁciency has
been reported to produce skeletal abnormalities, such as
osteoporosis [35]. In this study, we found that manganese
level in osteoporosis is lower than in normal bone. Low level
o fm a n g a n e s ei sn o tf o l l o w e db yh i g h e rl e v e lo fc a l c i u mi n
osteoporosis, which indicates that no substitution occurred
to these metals in the hydroxyapatite crystal. Therefore, we
suppose that manganese functions in the formation of or-
ganic matrix.
Zinc has been demonstrated to be an essential element
for normal growth of skeleton and bone metabolism. The
concentration of zinc in bone is higher than in the other tis-
sues [36]. Zinc is abundant atomic mineral in bone as a pro-
minent element for stimulus of bone formation in vitro and
in vivo as well as the inhibition of bone resorption. Zn also
supports metabolism and growth of bone, increases bone
density, and inhibits bone loss [37, 38]. Zinc, also involved in
bonding with organic structure [26]. Our study shows that
the deﬁciency of zinc was found in the osteoporosis bone.
This is the reason of imbalance between bone formation and
resorption activity in osteoporosis.
ˇ Sˇ canˇ car et al. found that concentration of strontium in
bone from autopsy subject was 13–60mg/kg [12]. According
to in vitro study, strontium induces maturation of human
primary osteoblast and apoptosis of human primary osteo-
clast at the same time [38]. Administration of low-dose
strontium in rat induces bone formation and in higher-dose
strontium would induce mineralization defect [39]. In this
study, strontium level in normal bone is higher than in the
osteoporosis bone, which is involved in bone formation. In
hydroxyapatite crystal, strontium was antagonist for calcium
[28]. In osteoporosis and normal bone, there is no converseThe Scientiﬁc World Journal 5
level between strontium and calcium. It means that there
is no substitution of strontium in the hydoxyapatite crystal
structure.
Lead in organic or inorganic forms is absorbed through
the lungs and gastrointestinal absorption. Organic leads also
absorbed through a skin. Inhalation exposure was more
common in occupational setting, whereas in the general
population through the ingestion route [40, 41]. Up to 94%
of the body burden of lead is in bone, where it has a half-life
of years to decades [40]. In vitro study shows that in osteo-
blast,leadwouldinhibitosteonectin/SPARCcalciumbinding
protein [42]. Lead induces osteoporosis through inhibition
of vitamin D and inhibits calcium absorption and disturbing
cellular function [43].Inthisstudy,leadlevelinnormalbone
is higher than in osteoporosis bone. It is caused by half-
life state in decade. Age of osteoporosis subject in this study
is twice that of normal subject. In osteoporosis bone, un-
bounding of lead would disturb cellular function yield im-
balance bone resorption and bone formation.
Selenium was a mineral found in soil and organism.
Selenium was incorporated into protein as selenocysteine.
Selenoproteinwasimportantforbonemetabolism.Thepop-
ulation with selenium deﬁciency was found higher in osteo-
porosis incidence [44]. In this study, we found that selenium
levelinnormalboneishigherthanthatofosteoporosisbone.
It means that selenium is important for bone metabolism
and selenium deﬁciency, which induces imbalance between
osteoblast and osteoclast activity. This reason is supported
by Moreno-Reyes et al. that the number of osteoblasts and
osteoclasts was higher in the selenium-deﬁcient rats and
associated with low plasma osteocalcin, a marker of osteo-
blast activity, and low urinary deoxypyridinoline concentra-
tion, a marker of bone resorption. Osteoblast activity was
impaired in the selenium-deﬁcient rats, and the increased
numberofosteoblastsmayrepresentacompensatoryprocess
to oﬀset decreased cell activity. The lower plasma osteocal-
cin associated with low urinary deoxypyridinoline concen-
trations may indicate that bone formation was depressed in
the selenium-deﬁcient rats [45].
Palladium, silver, and lantanadium are atomic minerals
for unknown function that need further investigation.
In summary, among these atoms, known to have impor-
tant roles in bone structure, we found involvement of atomic
mineral and calcium which are considerable to contribute
to osteoporotic phenomena. These mineral atomics would
determine bone mass density. To our knowledge, this study
is the ﬁrst time to provide such evidence. Consideration of
involvement of mineral atomic beside calcium in osteoporo-
sis is warranted to prevent osteoporosis.
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